Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia.
Simas, C; Munoz, N; Arregoces, L; LARSON, HJ;
2018
Human vaccines & immunotherapeutics, (2018).15 1 10.1080/21645515.2018.1511667.
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine.
WILDER-SMITH, A; Hombach, J; Ferguson, N; Selgelid, M; O'Brien, K; Vannice, K; Barrett, A; Ferdinand, E; FLASCHE, S; Guzman, M; Novaes, HM; Ng, L-C; SMITH, PG; Tharmaphornpilas, P; Yoon, I-K; Cravioto, A; Farrar, J; Nolan, TM;
2018
The Lancet infectious diseases, (2018).19 1 10.1016/S1473-3099(18)30494-8.
Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks.
Park, M; JIT, M; Wu, JT;
2018
BMC medicine, (2018).16 1 10.1186/s12916-018-1130-7.
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.
WAJJA, A; Namutebi, M; Apule, B; Oduru, G; Kiwanuka, S; Akello, M; Nassanga, B; Kabagenyi, J; Mpiima, J; Vermaak, S; Lawrie, A; Satti, I; Verweij, J; COSE, S; Levin, J; KALEEBU, P; Tukahebwa, E; McShane, H; ELLIOTT, AM;
2018
Wellcome open research, (2018).3, 10.12688/wellcomeopenres.14736.1.
Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination.
Hasso-Agopsowicz, M; Scriba, TJ; Hanekom, WA; DOCKRELL, HM; SMITH, SG;
2018
Scientific reports, (2018).8 1 10.1038/s41598-018-31537-9.
Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis.
Choi, HC W; JIT, M; Leung, GM; Tsui, K-L; Wu, JT;
2018
BMC medicine, (2018).16 1 10.1186/s12916-018-1118-3.
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?.
Preziosi, M-P; GREENWOOD, B;
2018
The Lancet infectious diseases, (2018).18 10 10.1016/S1473-3099(18)30430-4.
Prevention of Ebola virus disease through vaccination: where we are in 2018.
Lévy, Y; Lane, C; PIOT, P; Beavogui, AH; Kieh, M; Leigh, B; Doumbia, S; D'Ortenzio, E; Lévy-Marchal, C; Pierson, J; WATSON-JONES, D; Nguyen, V-K; LARSON, H; Lysander, J; Lacabaratz, C; Thiebaut, R; Augier, A; ISHOLA, D; Kennedy, S; Chêne, G; GREENWOOD, B; Neaton, J; Yazdanpanah, Y;
2018
Lancet, (2018).392 10149 10.1016/S0140-6736(18)31710-0.
Choices in vaccine trial design in epidemics of emerging infections.
Kahn, R; Rid, A; SMITH, PG; Eyal, N; Lipsitch, M;
2018
PLoS medicine, (2018).15 8 10.1371/journal.pmed.1002632.
Age of Infection with Kaposi Sarcoma-Associated Herpesvirus and Subsequent Antibody Values Among Children in Uganda.
NALWOGA, A; Miley, W; Labo, N; ELLIOTT, A; COSE, S; Whitby, D; NEWTON, R;
2018
The Pediatric infectious disease journal, (2018).37 8 10.1097/INF.0000000000001909.